Ribose Capsules
Natural health product licensed in Canada
- Other names
- Beta-D-ribofuranose Capsules
- Licence holder
- Holy Land Traditional Medications Inc.
- NPN or DIN-HM
- 80051167
- Status
- Active licence
- Licence date
- 27 May 2014
- Revision date
- 21 October 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D- | 550 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Eau purifiée, farine de riz, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 4 Capsule | 3 days |
Uses authorised in Canada
Workout supplement - Athletic support. Source of carbohydrates to support energy production. Source of calories which contributes to weight gain. Helps to [maintain performance/promote endurance] in extended (greater than 60 min), high intensity exercise.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ensure to adequately hydrate before, during, and after exercise. If you are pregnant or breastfeeding, consult a healthcare practitioner before using this product.
Source
Official Health Canada record, licence 80051167
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.